Aging converts innate B1a cells into potent CD8+ T cell inducers

Journal of Immunology

Volumn 196, Issue 8, 2016, Pages 3385-3397

  Lee Chang, Catalina ^a,b,c   Bodogai, Monica ^a   Moritoh, Kanako ^a   Chen, Xin ^d,e   Wersto, Robert ^a   Sen, Ranjan ^a   Young, Howard A ^e   Croft, Michael ^f   Ferrucci, Luigi ^a   Biragyn, Arya ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITÉ DE LILLE   (France)

^c UNIV LILLE   (France)

^d University of Macau   (Macao)

^e NATIONAL CANCER INSTITUTE   (United States)

^f LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 LIGAND; CD86 ANTIGEN; GAMMA INTERFERON RECEPTOR 1; GRANZYME B; TUMOR NECROSIS FACTOR ALPHA; GAMMA INTERFERON RECEPTOR; GRANZYME; GZMB PROTEIN, MOUSE; HLA ANTIGEN CLASS 1; INTERFERON RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

4BL CELL; AGED; AGING; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B1A CELL; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; LYMPHOCYTE TRANSFORMATION; MONOCYTE; MOUSE; NONHUMAN; NORMAL HUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ADULT; ANIMAL; AUTOIMMUNITY; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL AGING; CELL CULTURE; CYTOLOGY; ENZYME ACTIVATION; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; NEOPLASM; PATHOLOGY;

4-1BB LIGAND; ADULT; AGED; AGING; ANIMALS; ANTIGENS, CD86; AUTOIMMUNITY; B-LYMPHOCYTE SUBSETS; CD8-POSITIVE T-LYMPHOCYTES; CELL AGING; CELLS, CULTURED; ENZYME ACTIVATION; FEMALE; GRANZYMES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LYMPHOCYTE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; NEOPLASMS; RECEPTORS, INTERFERON; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84974803177     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502034     Document Type: Article

References (74)

1. Le Saux, S., C. M. Weyand, and J. J. Goronzy. 2012. Mechanisms of immunosenescence: lessons from models of accelerated immune aging. Ann. N. Y. Acad. Sci. 1247: 69-82.
2. Rodier, F., and J. Campisi. 2011. Four faces of cellular senescence. J. Cell Biol. 192: 547-556.
3. Sudo, K., H. Ema, Y. Morita, and H. Nakauchi. 2000. Age-associated characteristics of murine hematopoietic stem cells. J. Exp. Med. 192: 1273-1280.
4. Morrison, S. J., A. M. Wandycz, K. Akashi, A. Globerson, and I. L. Weissman. 1996. The aging of hematopoietic stem cells. Nat. Med. 2: 1011-1016.
5. Roeder, I., K. Horn, H. B. Sieburg, R. Cho, C. Muller-Sieburg, and M. Loeffler. 2008. Characterization and quantification of clonal heterogeneity among hematopoietic stem cells: a model-based approach. Blood 112: 4874-4883.
6. Cho, R. H., H. B. Sieburg, and C. E. Muller-Sieburg. 2008. A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood 111: 5553-5561.
7. Kuranda, K., J. Vargaftig, P. de la Rochere, C. Dosquet, D. Charron, F. Bardin, C. Tonnelle, D. Bonnet, and M. Goodhardt. 2011. Age-related changes in human hematopoietic stem/progenitor cells. Aging Cell 10: 542-546.
8. Hearps, A. C., G. E. Martin, T. A. Angelovich, W. J. Cheng, A. Maisa, A. L. Landay, A. Jaworowski, and S. M. Crowe. 2012. Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell 11: 867-875.
9. Bouchlaka, M. N., G. D. Sckisel, M. Chen, A. Mirsoian, A. E. Zamora, E. Maverakis, D. E. Wilkins, K. L. Alderson, H. H. Hsiao, J. M. Weiss, et al. 2013. Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy. J. Exp. Med. 210: 2223-2237.
10. Smallwood, H. S., D. López-Ferrer, and T. C. Squier. 2011. Aging enhances the production of reactive oxygen species and bactericidal activity in peritoneal macrophages by upregulating classical activation pathways. Biochemistry 50: 9911-9922.
11. Linehan, E., Y. Dombrowski, R. Snoddy, P. G. Fallon, A. Kissenpfennig, and D. C. Fitzgerald. 2014. Aging impairs peritoneal but not bone marrow-derived macrophage phagocytosis. Aging Cell 13: 699-708.
12. Mancuso, P., R. W. McNish, M. Peters-Golden, and T. G. Brock. 2001. Evaluation of phagocytosis and arachidonate metabolism by alveolar macrophages and recruited neutrophils from F344xBN rats of different ages. Mech. Ageing Dev. 122: 1899-1913.
13. Kline, G. H., T. A. Hayden, and N. R. Klinman. 1999. B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J. Immunol. 162: 3342-3349.
14. Johnson, K. M., K. Owen, and P. L. Witte. 2002. Aging and developmental transitions in the B cell lineage. Int. Immunol. 14: 1313-1323.
15. Koch, S., A. Larbi, E. Derhovanessian, D. Ozcelik, E. Naumova, and G. Pawelec. 2008. Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. Immun. Ageing 5: 6.
16. Lerner, A., T. Yamada, and R. A. Miller. 1989. Pgp-1hi T lymphocytes accumulate with age in mice and respond poorly to concanavalin A. Eur. J. Immunol. 19: 977-982.
17. Guerrettaz, L. M., S. A. Johnson, and J. C. Cambier. 2008. Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging. Proc. Natl. Acad. Sci. USA 105: 11898-11902.
18. Cancro, M. P., and D. M. Allman. 2005. Connecting the dots: revealing the interactions of lymphocyte development and homeostasis in the immunobiology of aging. Semin. Immunol. 17: 319-320.
19. Barber, C. L., E. Montecino-Rodriguez, and K. Dorshkind. 2011. Reduced production of B-1-specified common lymphoid progenitors results in diminished potential of adult marrow to generate B-1 cells. Proc. Natl. Acad. Sci. USA 108: 13700-13704.
20. Alter-Wolf, S., B. B. Blomberg, and R. L. Riley. 2009. Old mice retain bone marrow B1 progenitors, but lose B2 precursors, and exhibit altered immature B cell phenotype and light chain usage. Mech. Ageing Dev. 130: 401-408.
21. Stall, A. M., M. C. Fariñas, D. M. Tarlinton, P. A. Lalor, L. A. Herzenberg, S. Strober, and L. A. Herzenberg. 1988. Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals. Proc. Natl. Acad. Sci. USA 85: 7312-7316.
22. Herzenberg, L. A., N. Baumgarth, and J. A. Wilshire. 2000. B-1 cell origins and VH repertoire determination. Curr. Top. Microbiol. Immunol. 252: 3-13.
23. Hayakawa, K., R. R. Hardy, D. R. Parks, and L. A. Herzenberg. 1983. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J. Exp. Med. 157: 202-218.
24. Caligaris-Cappio, F., M. Gobbi, M. Bofill, and G. Janossy. 1982. Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J. Exp. Med. 155: 623-628.
25. Hardy, R. R., and K. Hayakawa. 2001. B cell development pathways. Annu. Rev. Immunol. 19: 595-621.
26. Perez-Andres, M., C. Grosserichter-Wagener, C. Teodosio, J. J. van Dongen, A. Orfao, and M. C. van Zelm. 2011. The nature of circulating CD27+CD43+ B cells. J. Exp. Med. 208: 2565-2566.
27. Griffin, D. O., N. E. Holodick, and T. L. Rothstein. 2011. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-. J. Exp. Med. 208: 67-80.
28. Descatoire, M., J. C. Weill, C. A. Reynaud, and S. Weller. 2011. A human equivalent of mouse B-1 cells? J. Exp. Med. 208: 2563-2564.
29. Hao, Y., P. O'Neill, M. S. Naradikian, J. L. Scholz, and M. P. Cancro. 2011. A Bcell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood 118: 1294-1304.
30. Lee-Chang, C., M. Bodogai, K. Moritoh, P. B. Olkhanud, A. C. Chan, M. Croft, J. A. Mattison, P. J. Holst, R. E. Gress, L. Ferrucci, et al. 2014. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood 124: 1450-1459.
31. Wang, C., G. H. Lin, A. J. McPherson, and T. H. Watts. 2009. Immune regulation by 4-1BB and 4-1BBL: complexities and challenges. Immunol. Rev. 229: 192-215.
32. Futagawa, T., H. Akiba, T. Kodama, K. Takeda, Y. Hosoda, H. Yagita, and K. Okumura. 2002. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. Int. Immunol. 14: 275-286.
33. Cooper, D., P. Bansal-Pakala, and M. Croft. 2002. 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity. Eur. J. Immunol. 32: 521-529.
34. Watts, T. H., and M. A. DeBenedette. 1999. T cell co-stimulatory molecules other than CD28. Curr. Opin. Immunol. 11: 286-293.
35. Shuford, W. W., K. Klussman, D. D. Tritchler, D. T. Loo, J. Chalupny, A. W. Siadak, T. J. Brown, J. Emswiler, H. Raecho, C. P. Larsen, et al. 1997. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186: 47-55.
36. Kim, H. J., J. S. Lee, J. D. Kim, H. J. Cha, A. Kim, S. K. Lee, S. C. Lee, B. S. Kwon, R. S. Mittler, H. R. Cho, and B. Kwon. 2012. Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation. Proc. Natl. Acad. Sci. USA 109: E13-E22.
37. Gramaglia, I., D. Cooper, K. T. Miner, B. S. Kwon, and M. Croft. 2000. Costimulation of antigen-specific CD4 T cells by 4-1BB ligand. Eur. J. Immunol. 30: 392-402.
38. Zhao, Y., and M. Croft. 2012. Dispensable role for 4-1BB and 4-1BBL in development of vaccinia virus-specific CD8 T cells. Immunol. Lett. 141: 220-226.
39. Hodge, D. L., C. Berthet, V. Coppola, W. Kastenmüller, M. D. Buschman, P. M. Schaughency, H. Shirota, A. J. Scarzello, J. J. Subleski, M. R. Anver, et al. 2014. IFN-γamma AU-rich element removal promotes chronic IFN-γamma expression and autoimmunity in mice. J. Autoimmun. 53: 33-45.
40. Zhao, Y., V. Tahiliani, S. Salek-Ardakani, and M. Croft. 2012. Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens. Front. Immunol. 3: 332.
41. Schiavo, R., D. Baatar, P. Olkhanud, F. E. Indig, N. Restifo, D. Taub, and A. Biragyn. 2006. Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responses. Blood 107: 4597-4605.
42. Yanaba, K., J. D. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto, and T. F. Tedder. 2008. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650.
43. Pérez, E. C., J. Machado, Jr., F. Aliperti, E. Freymüller, M. Mariano, and J. D. Lopes. 2008. B-1 lymphocytes increase metastatic behavior of melanoma cells through the extracellular signal-regulated kinase pathway. Cancer Sci. 99: 920-928.
44. Bodogai, M., C. Lee Chang, K. Wejksza, J. Lai, M. Merino, R. P. Wersto, R. E. Gress, A. C. Chan, C. Hesdorffer, and A. Biragyn. 2013. Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L. Cancer Res. 73: 2127-2138.
45. Overwijk, W. W., M. R. Theoret, S. E. Finkelstein, D. R. Surman, L. A. de Jong, F. A. Vyth-Dreese, T. A. Dellemijn, P. A. Antony, P. J. Spiess, D. C. Palmer, et al. 2003. Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J. Exp. Med. 198: 569-580.
46. Carrasco, Y. R., and F. D. Batista. 2007. B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity 27: 160-171.
47. Harvey, B. P., T. E. Quan, B. J. Rudenga, R. M. Roman, J. Craft, and M. J. Mamula. 2008. Editing antigen presentation: antigen transfer between human B lymphocytes and macrophages mediated by class A scavenger receptors. J. Immunol. 181: 4043-4051.
48. Seda, V., and M. Mraz. 2015. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells. Eur. J. Haematol. 94: 193-205.
49. Langstein, J., J. Michel, J. Fritsche, M. Kreutz, R. Andreesen, and H. Schwarz. 1998. CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. J. Immunol. 160: 2488-2494.
50. Quintáns, J., and I. Lefkovits. 1974. Clonal expansion of lipopolysaccharidestimulated B lymphocytes. J. Immunol. 113: 1373-1376.
51. Guilloton, F., A. de Thonel, C. Jean, C. Demur, V. Mansat-De Mas, G. Laurent, and A. Quillet-Mary. 2005. TNFalpha stimulates NKG2D-mediated lytic activity of acute myeloid leukemic cells. Leukemia 19: 2206-2214.
52. McPherson, A. J., L. M. Snell, T. W. Mak, and T. H. Watts. 2012. Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells. J. Biol. Chem. 287: 23010-23019.
53. Huang, C., E. Bi, Y. Hu, W. Deng, Z. Tian, C. Dong, Y. Hu, and B. Sun. 2006. A novel NF-κappaB binding site controls human granzyme B gene transcription. J. Immunol. 176: 4173-4181.
54. Curiel, R. E., C. S. Garcia, S. Rottschafer, M. C. Bosco, and I. Espinoza-Delgado. 1999. Enhanced B7-2 gene expression by interferon-gamma in human monocytic cells is controlled through transcriptional and posttranscriptional mechanisms. Blood 94: 1782-1789.
55. Sasaki, S., M. Sullivan, C. F. Narvaez, T. H. Holmes, D. Furman, N. Y. Zheng, M. Nishtala, J. Wrammert, K. Smith, J. A. James, et al. 2011. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J. Clin. Invest. 121: 3109-3119.
56. Wols, H. A., K. M. Johnson, J. A. Ippolito, S. Z. Birjandi, Y. Su, P. T. Le, and P. L. Witte. 2010. Migration of immature and mature B cells in the aged microenvironment. Immunology 129: 278-290.
57. Berberich, S., R. Förster, and O. Pabst. 2007. The peritoneal micromilieu commits B cells to home to body cavities and the small intestine. Blood 109: 4627-4634.
58. Ishikawa, S., T. Sato, M. Abe, S. Nagai, N. Onai, H. Yoneyama, Y. Zhang, T. Suzuki, S. Hashimoto, T. Shirai, et al. 2001. Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J. Exp. Med. 193: 1393-1402.
59. Weksler, M. E. 2000. Changes in the B-cell repertoire with age. Vaccine 18: 1624-1628.
60. Dauphinée, M., Z. Tovar, and N. Talal. 1988. B cells expressing CD5 are increased in Sjögren's syndrome. Arthritis Rheum. 31: 642-647.
61. Ito, T., S. Ishikawa, T. Sato, K. Akadegawa, H. Yurino, M. Kitabatake, S. Hontsu, T. Ezaki, H. Kimura, and K. Matsushima. 2004. Defective B1 cell homing to the peritoneal cavity and preferential recruitment of B1 cells in the target organs in a murine model for systemic lupus erythematosus. J. Immunol. 172: 3628-3634.
62. Chen, Y., Y.-B. Park, E. Patel, and G. J. Silverman. 2009. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J. Immunol. 182: 6031-6043.
63. Martinez, L., C. Gomez, and R. I. Vazquez-Padron. 2015. Age-related changes in monocytes exacerbate neointimal hyperplasia after vascular injury. Oncotarget 6: 17054-17064.
64. Yoon, P., K. T. Keylock, M. E. Hartman, G. G. Freund, and J. A. Woods. 2004. Macrophage hypo-responsiveness to interferon-gamma in aged mice is associated with impaired signaling through Jak-STAT. Mech. Ageing Dev. 125: 137-143.
65. Herrero, C., L. Marqués, J. Lloberas, and A. Celada. 2001. IFN-γammadependent transcription of MHC class II IA is impaired in macrophages from aged mice. J. Clin. Invest. 107: 485-493.
66. Renshaw, M., J. Rockwell, C. Engleman, A. Gewirtz, J. Katz, and S. Sambhara. 2002. Cutting edge: impaired Toll-like receptor expression and function in aging. J. Immunol. 169: 4697-4701.
67. Kilmon, M. A., N. J. Wagner, A. L. Garland, L. Lin, K. Aviszus, L. J. Wysocki, and B. J. Vilen. 2007. Macrophages prevent the differentiation of autoreactive B cells by secreting CD40 ligand and interleukin-6. Blood 110: 1595-1602.
68. Szakal, A. K., Y. Aydar, P. Balogh, and J. G. Tew. 2002. Molecular interactions of FDCs with B cells in aging. Semin. Immunol. 14: 267-274.
69. Wong, S. C., A. L. Puaux, M. Chittezhath, I. Shalova, T. S. Kajiji, X. Wang, J. P. Abastado, K. P. Lam, and S. K. Biswas. 2010. Macrophage polarization to a unique phenotype driven by B cells. Eur. J. Immunol. 40: 2296-2307.
70. Grewal, I. S., and R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16: 111-135.
71. Bergtold, A., D. D. Desai, A. Gavhane, and R. Clynes. 2005. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 23: 503-514.
72. Howard, W. A., K. L. Gibson, and D. K. Dunn-Walters. 2006. Antibody quality in old age. Rejuvenation Res. 9: 117-125.
73. Kang, Y. J., S. O. Kim, S. Shimada, M. Otsuka, A. Seit-Nebi, B. S. Kwon, T. H. Watts, and J. Han. 2007. Cell surface 4-1BBL mediates sequential signaling pathways 'downstream' of TLR and is required for sustained TNF production in macrophages. Nat. Immunol. 8: 601-609.
74. Zhou, F. 2009. Molecular mechanisms of IFN-γamma to up-regulate MHC class I antigen processing and presentation. Int. Rev. Immunol. 28: 239-260.